MedPath

Neovasc Inc.

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

REDUCER-I: An Observational Study of the Neovasc Reducerâ„¢ System

Active, not recruiting
Conditions
Chronic Stable Angina
Angina Pectoris
Angina Pectoris, Stable
Interventions
Device: Reducer System
First Posted Date
2016-03-16
Last Posted Date
2025-01-01
Lead Sponsor
Neovasc Inc.
Target Recruit Count
400
Registration Number
NCT02710435
Locations
🇧🇪

ZNA Middelheim Hospital, Antwerpen, Belgium

🇧🇪

Zienkenhuis Oost-Limburg, Genk, Belgium

🇫🇷

University Hospital of Brest, Brest, France

and more 22 locations

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA

Phase 2
Completed
Conditions
Refractory Angina
Interventions
Device: Neovasc Reducer
Device: Control
First Posted Date
2010-09-21
Last Posted Date
2013-11-25
Lead Sponsor
Neovasc Inc.
Target Recruit Count
104
Registration Number
NCT01205893
Locations
🇧🇪

ZNA Middelheim Hospital, Antwerpen, Belgium

🇧🇪

Ziekenhuis Oost-Limburg, Genk, Belgium

🇨🇦

Montreal Heart Institute, Montreal, Quebec, Canada

and more 8 locations

Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.

Phase 2
Completed
Conditions
Angioplasty
First Posted Date
2006-11-15
Last Posted Date
2009-05-13
Lead Sponsor
Neovasc Inc.
Target Recruit Count
145
Registration Number
NCT00399646
Locations
🇺🇸

Pasco Cardiology Center, Hudson, Florida, United States

🇺🇸

Columbia Presbyterian Hospital, New York, New York, United States

🇳🇱

Medisch Centrum Rijmond Zuid, Rotterdam, The Netherlands, Netherlands

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath